Publikationen in Zusammenarbeit mit Forschern von Radboud University Nijmegen Medical Centre (7)

2022

  1. Tenofovir Alafenamide Plasma Concentrations Are Reduced in Pregnant Women Living With Human Immunodeficiency Virus (HIV): Data From the PANNA Network

    Clinical Infectious Diseases, Vol. 75, Núm. 4, pp. 623-629

2021

  1. First pharmacokinetic data of bictegravir in pregnant women living with HIV

    AIDS

  2. The Effect of Pregnancy on the Pharmacokinetics of Total and Unbound Dolutegravir and Its Main Metabolite in Women Living with Human Immunodeficiency Virus

    Clinical Infectious Diseases, Vol. 72, Núm. 1, pp. 121-127

2019

  1. Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis

    The Lancet Infectious Diseases, Vol. 19, Núm. 8, pp. 880-891

2015

  1. Atazanavir exposure is effective during pregnancy regardless of tenofovir use

    Antiviral Therapy, Vol. 20, Núm. 1, pp. 57-64

  2. Maraviroc Pharmacokinetics in HIV-1-Infected Pregnant Women

    Clinical Infectious Diseases, Vol. 61, Núm. 10, pp. 1582-1589

  3. Raltegravir in HIV-1-infected pregnant women: Pharmacokinetics, safety, and efficacy

    Clinical Infectious Diseases, Vol. 61, Núm. 5, pp. 809-816